Abstract
Observations were made of the antifattyliver effect of tri-phenyl-ethanol (TPE) on experimentally induced ratfattyliver.
Clinical effects of the drug were also reviewed to cases of cholesteremia.
A fattyliver due to CCl4 showed more increase in total cholesterol, neutral fat and total fat than a fattyliver due to CCl4 and TPE. Oral administration of 6 tablets a TPE daily to cases with cholesteremia for 30 days resulted in decrease of 25 percent of the pre-administstage in serum cholesterol, ie.71.47mg/dl on an average.